Mineralocorticoid Action: Target Tissue Specificity Is Enzyme, Not Receptor, Mediated
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Mineralocorticoid receptors, both when in tissue extracts and when recombinant-derived, have equal affinity for the physiological mineralocorticoid aldosterone and for the glucocorticoids cortisol and corticosterone, which circulate at much higher concentrations than aldosterone. Such receptors are found in physiological mineralocorticoid target tissues (kidney, parotid, and colon) and in nontarget tissues such as hippocampus and heart. In mineralocorticoid target tissues the receptors are selective for aldosterone in vivo because of the presence of the enzyme 11 β-hydroxy-steroid dehydrogenase, which converts cortisol and corticosterone, but not aldosterone, to their 11-keto analogs. These analogs cannot bind to mineralocorticoid receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mineralocorticoid-responsive tissues such as the kidney, cortisol is enzymatically converted to cortisone, a metabolically inactive steroid (569).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“Thus, the type 2 enzyme inactivates the mineralocorticoid activity of cortisol in the kidney tubule (569), and inactivating mutations in the type 2 enzyme cause a syndrome of apparent mineralocorticoid excess (AME) (588).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“Thus, 11HSD2 prevents cortisol from overwhelming renal mineralocorticoid receptors (569), and in the placenta and other fetal tissues 11HSD2 (583, 584) also inactivates cortisol.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“The kidney has high levels of HSD11B2 activity which protects the mineralocorticoid receptor from activation by cortisol by inactivating it to cortisone (Edwards and Stewart, 1991, Funder et al., 1988).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Funder et al., 1988
Citations
Cites
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Stewart, P., Valentino, R., Wallace, A. M., Burt, D., Shackleton, C. L., & Edwards, C. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91014-2 · Cited by 803
Krozowski, Z. S., & Funder, J. W. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.6056 · Cited by 523
Self-citationThe Roles of Plasma Binding and Receptor Specificity in the Mineralocorticoid Action of Aldosterone1
FUNDER, J. W., FELDMAN, D., & EDELMAN, I. S. (1973) · Endocrinology · doi:10.1210/endo-92-4-994 · Cited by 232
Self-citationCharacterization of Rat Brain Aldosterone Receptors Reveals High Affinity for Corticosterone
BEAUMONT, K., & FANESTIL, D. D. (1983) · Endocrinology · doi:10.1210/endo-113-6-2043 · Cited by 193
Pearson Murphy, B. E. (1981) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(81)90226-0 · Cited by 178
Glucocorticoid Receptors in Rat Kidney: The Rinding of Tritiated-Dexamethasone1
FUNDER, J. W., FELDMAN, D., & EDELMAN, I. S. (1973) · Endocrinology · doi:10.1210/endo-92-4-1005 · Cited by 173
Self-citationAFFINITY OF LIQUORICE DERIVATIVES FOR MINERALOCORTICOID AND GLUCOCORTICOID RECEPTORS
ARMANINI, D., KARBOWIAK, I., & FUNDER, J. W. (1983) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1983.tb00038.x · Cited by 157
Self-citationGlucocorticoid and mineralocorticoid receptors for aldosterone
Rousseau, G. G., Baxter, J. D., Funder, J. W., Edelman, I. S., & Tomkins, G. M. (1972) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(72)90053-2 · Cited by 151
Self-citation
Research works printed but not linked: 4
- Krozowski, Z. S., Proceedings of the National Academy of Sciences of the United States of America 80: 6056 (1983).
- SHEPPARD, K, MINERALOCORTICOID SPECIFICITY OF RENAL TYPE-I RECEPTORS - INVIVO BINDING-STUDIES, AMERICAN JOURNAL OF PHYSIOLOGY 252: E224 (1987).
- SHEPPARD, K, TYPE-I RECEPTORS IN PAROTID, COLON, AND PITUITARY ARE ALDOSTERONE SELECTIVE INVIVO, AMERICAN JOURNAL OF PHYSIOLOGY 253: E467 (1987).
- STEWART, P.M., CORTICOSTEROIDS PEPT 39: 163 (1987).
Cited by
Items 301–400 of 1,001
Bachmann, S., Bostanjoglo, M., Schmitt, R., & Ellison, D. H. (1999) · Anatomy and Embryology · doi:10.1007/s004290050294 · Cited by 100
The role of SGK1 in hormone-regulated sodium transport
Pearce, D. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00439-8 · Cited by 100
Kristanc, L., & Kreft, S. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.04.007 · Cited by 101
“Subsequently, the activity of cortisol, which binds as avidly to the mineralocorticoid receptor as aldosterone, is increased (Funder et al., 1988).”
Backgroundde Klerk, G. J., Nieuwenhuis, M. G., & Beutler, J. J. (1997) · BMJ · doi:10.1136/bmj.314.7082.731 · Cited by 99
VOICE, M. W., SECKL, J. R., EDWARDS, C. R. W., & CHAPMAN, K. E. (1996) · Biochemical Journal · doi:10.1042/bj3170621 · Cited by 92
Cushing’s Syndrome: All Variants, Detection, and Treatment
Sharma, S. T., & Nieman, L. K. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.01.006 · Cited by 89
“The in vivo selectivity of the renal mineralocorticoid receptor for aldosterone requires conversion of cortisol to cortisone by 11bHSD2, rendering it unable to bind to the mineralocorticoid receptor.(28,29) The global activity of 11bHSD can be assessed by measurement of urinary steroid”
BackgroundCentral Hypertensive Effects of Aldosterone
Gómez-Sánchez, E. P. (1997) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1997.0157 · Cited by 99
Perry, R. J., Resch, J. M., Douglass, A. M., Madara, J. C., Rabin-Court, A., Kucukdereli, H., Wu, C., Song, J. D., Lowell, B. B., & Shulman, G. I. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901795116 · Cited by 91
Aldosterone-Specific Activation of Cardiomyocyte Mineralocorticoid Receptor In Vivo
Messaoudi, S., Gravez, B., Tarjus, A., Pelloux, V., Ouvrard‐Pascaud, A., Delcayre, C., Samuel, J., Launay, J., Sierra‐Ramos, C., de la Rosa, D. Á., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.112.198986 · Cited by 98
“The MR selectivity for aldosterone is achieved by the coexpression of the 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2), which inactivates glucocorticoids.(15) Because 11β-HSD2 activity is low in cardiomyocytes,(16) the beneficial effects of MR blockade in clinical studies may result from inhibition of glucocorti…”
BackgroundDisturbances of Na/K Balance: Pseudohypoaldosteronism Revisited
Bonny, O., & Rossier, B. C. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000028641.59030.b2 · Cited by 98
Nongenomic effects of mineralocorticoid receptor activation in the cardiovascular system
Mihailidou, A. S., & Funder, J. W. (2005) · Steroids · doi:10.1016/j.steroids.2005.02.004 · Cited by 98
Self-citationInsights into glucocorticoid-associated hypertension
Brem, A. S. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.20637 · Cited by 98
Martinerie, L., Viengchareun, S., Delezoide, A.-L., Jaubert, F., Sinico, M., Prevot, S., Boileau, P., Meduri, G., & Lombès, M. (2009) · Endocrinology · doi:10.1210/en.2008-1498 · Cited by 97
Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy
Heier, C. R., Yu, Q., Fiorillo, A. A., Tully, C., Tucker, A., Mázala, D. A. G., Uaesoontrachoon, K., Srinivassane, S., Damsker, J. M., Hoffman, E. P., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201800186 · Cited by 97
“This enzyme is speci fi cally expressed in epithelial tissues and metabolizes excess glucocorticoids (cortisol and prednisolone) into their inactive forms (cortisone and prednisone) (Funder et al, 1988).”
Hill, M. A., Jaisser, F., & Sowers, J. R. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa326 · Cited by 97
Aldosterone: Its Receptor, Target Genes, and Actions
Pearce, D., Bhargava, A., & Cole, T. J. (2003) · Vitamins and hormones · doi:10.1016/s0083-6729(03)01002-1 · Cited by 98
Summa, V., Mordasini, D., Roger, F., Bens, M., Martin, P., Vandewalle, A., Verrey, F., & Féraille, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107165200 · Cited by 97
Aldosterone, SGK1, and ion channels in the kidney
Valinsky, W. C., Touyz, R. M., & Shrier, A. (2018) · Clinical Science · doi:10.1042/cs20171525 · Cited by 82
Hastings, M. H. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90072-t · Cited by 97
Walker, B. R. (1992) · Endocrinology · doi:10.1210/en.131.2.970 · Cited by 90
Glucocorticoid-dependent hypertension
Mantero, F., & Boscaro, M. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90077-v · Cited by 96
Differential action of steroid hormones on human endothelium
Oberleithner, H., Riethmüller, C., Ludwig, T. E., Shahin, V., Stock, C. M., Schwab, A., Hausberg, M., Kusche, K., & Schillers, H. (2006) · Journal of Cell Science · doi:10.1242/jcs.02886 · Cited by 95
“Our results support the view that glucocorticoids regulate intercellular junctions and thus determine paracellular permeability, while, in contrast, aldosterone lacks such effects but decreases cell elasticity.”
BackgroundResultHan, K. H., Kang, Y. S., Han, S. Y., Jee, Y. H., Lee, M. H., Han, J., Kim, H. K., Kim, Y. S., & Cha, D. R. (2006) · Kidney International · doi:10.1038/sj.ki.5000438 · Cited by 95
“For instance, MCs have both 11 β -HSD2 and MR, which suggests that MCs have high aldosterone sensitivity”
BackgroundCole, T. J. (1995) · Endocrinology · doi:10.1210/en.136.10.4693 · Cited by 86
Environmental inhibitors of 11β-hydroxysteroid dehydrogenase type 2
Ma, X., Lian, Q.-Q., Dong, Q., & Ge, R.-S. (2011) · Toxicology · doi:10.1016/j.tox.2011.04.007 · Cited by 94
Aldosterone and Mineralocorticoid Receptors in the Cardiovascular System
Funder, J. W. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.12.003 · Cited by 94
Self-citationKolkhof, P., Joseph, A., & Kintscher, U. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105859 · Cited by 94
Liu, Y., Nakagawa, Y., Wang, Y., Li, R., Li, X., Ohzeki, T., & Friedman, T. C. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1409 · Cited by 79
Pascual-Le Tallec, L., Simone, F., Viengchareun, S., Meduri, G., Thirman, M. J., & Lombès, M. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0331 · Cited by 82
Aldosterone and the Cardiovascular System: Genomic and Nongenomic Effects
Funder, J. W. (2006) · Endocrinology · doi:10.1210/en.2006-0826 · Cited by 82
Self-citationMoore, C. C., Mellon, S. H., Murai, J., Siiteri, P. K., & Miller, W. L. (1993) · Endocrinology · doi:10.1210/endo.133.1.8319583 · Cited by 93
Advances in the epidemiology, pathogenesis, and management of Cushing’s syndrome complications
Arnaldi, G., Mancini, T., Tirabassi, G., Trementino, L., & Boscaro, M. (2012) · Journal of Endocrinological Investigation · doi:10.1007/bf03345431 · Cited by 93
“Thus, the conversion of cortisol to cortisone mediated by enzyme 11β- hydroxysteroid dehydrogenase (11β-HSD) type 2 (11β-HSD-2) is crucial for enabling cortisol to bind to the renal mineralocorticoid receptor and ensuring its selectivity for aldosterone (13, 14).”
Sodium Intake and Vascular Stiffness in Hypertension
Safar, M. E., Temmar, M., Kakou, A., Lacolley, P., & Thornton, S. N. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.129585 · Cited by 83
Nguyen Dinh Cat, A., Briones, A. M., Callera, G. E., Yogi, A., He, Y., Montezano, A. C., & Touyz, R. M. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.168872 · Cited by 84
Mechanistic aspects of mineralocorticoid receptor activation
Hellal-Levy, C., Fagart, J., Souque, A., & Rafestin-Oblin, M.-E. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00958.x · Cited by 78
Ecdysteroids and related molecules in animals and plants
Lafont, R. (1997) · Archives of Insect Biochemistry and Physiology · doi:10.1002/(sici)1520-6327(1997)35:1/2<3::aid-arch2>3.0.co;2-x · Cited by 86
Apparent mineralocorticoid excess syndrome: an overview
Palermo, M., Quinkler, M., & Stewart, P. M. (2004) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302004000500015 · Cited by 92
Mohammed, S. F., Ohtani, T., Korinek, J. K., Lam, C. S. P., Larsen, K., Simari, R. D., Valencik, M. L., Burnett, J. C. J., & Redfield, M. M. (2010) · Circulation · doi:10.1161/circulationaha.109.915215 · Cited by 92
Inherited Forms of Mineralocorticoid Hypertension
White, P. C. (1996) · Hypertension · doi:10.1161/01.hyp.28.6.927 · Cited by 92
Bland, R., Worker, C., Noble, B., Eyre, L., Bujalska, I., Sheppard, M., Stewart, P., & Hewison, M. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1610455 · Cited by 80
Apparent Mineralocorticoid Excess: Genotype Is Correlated With Biochemical Phenotype
Mune, T., & White, P. C. (1996) · Hypertension · doi:10.1161/01.hyp.27.6.1193 · Cited by 86
Yehuda, R., Bierer, L. M., Andrew, R., Schmeidler, J., & Seckl, J. R. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.12.003 · Cited by 90
“Under such conditions, the effects of glucocorticoids within specific cell types could be amplified despite a reduced rate of adrenal glucocorticoid production, which in turn could contribute to changes in glucocorticoid receptor regulation of cortisol (Lovati et al., 1999; Funder et al., 1988).”
Kiilerich, P., Kristiansen, K., & Madsen, S. S. (2006) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2006.12.018 · Cited by 90
Ferrari, P. (2003) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/s1521-690x(03)00053-8 · Cited by 90
Shimojo, M., Ricketts, M. L., Petrelli, M. D., Moradi, P., Johnson, G. D., Bradwell, A. R., Hewison, M., Howie, A. J., & Stewart, P. M. (1997) · Endocrinology · doi:10.1210/endo.138.3.4994 · Cited by 80
The role of the 11β-hydroxysteroid dehydrogenase type 2 in human hypertension
Ferrari, P., Lovati, E., & Frey, F. J. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018030-00001 · Cited by 90
Identification of C. elegans DAF-12-binding sites, response elements, and target genes
Shostak, Y., Gilst, M. V., Antebi, A., & Yamamoto, K. (2004) · Genes & Development · doi:10.1101/gad.1218504 · Cited by 90
“IRs control global developmental and physiological gene networks; a given IR typically plays distinct roles in different tissues and developmental times (Ashburner 1990; Yamamoto et al. 1992; Tsai and O’Malley 1994; Yamamoto 1995; Chawla et al. 2001; Thummel 2001).”
BackgroundInfluential11β-hydroxysteroid dehydrogenases: A growing multi-tasking family
Gómez-Sánchez, E. P., & Gómez-Sánchez, C. E. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111210 · Cited by 89
Queisser, N., & Schupp, N. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.011 · Cited by 89
“glucocorticoids, the enzyme 11b-hydroxysteroid dehydrogenase type 2 (11bHSD2) metabolizes a high proportion of glucocorticoids to cortisone in aldosterone target cells, so that they cannot activate the MR [191].”
Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology
Cannavò, A., Bencivenga, L., Liccardo, D., Elia, A., Marzano, F., Gambino, G., D’Amico, M. L., Perna, C., Ferrara, N., Rengo, G., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1204598 · Cited by 91
“However, the evidence that PGC-1α is expressed at high levels in brown adipose tissue, where MRs participate in adipocyte differentiation [36], suggests the existence of ligand and cell-specific MR coactivators [37, 38].”
Background11β-hydroxysteroid dehydrogenase mediates reductive metabolism of xenobiotic carbonyl compounds
Maser, E., & Bannenberg, G. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90309-3 · Cited by 89
Young, M. J., & Funder, J. W. (2002) · Journal of Hypertension · doi:10.1097/00004872-200208000-00002 · Cited by 89
Self-citationKROZOWSKI, Z., STUCHBERY, S., WHITE, P., MONDER, C., & FUNDER, J. W. (1990) · Endocrinology · doi:10.1210/endo-127-6-3009 · Cited by 86
Self-citationCruz, S. A., Lin, C.-H., Chao, P.-L., & Hwang, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077997 · Cited by 88
McCormick, S. D. (2009) · Integrative and Comparative Biology · doi:10.1093/icb/icp044 · Cited by 88
“The presence of hormonespecific enzymes in some tissues, such as the 11b-hydroxystreroid dehydrogenase which degrades cortisol but not aldosterone, provides more tissuespecific regulation of hormonal response (Funder et al. 1988).”
BackgroundPathogenesis of the Type 2 Variant of the Syndrome of Apparent Mineralocorticoid Excess*
ULICK, S., TEDDE, R., & MANTERO, F. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-1-200 · Cited by 83
Jellinck, P. H., Monder, C., McEwen, B. S., & Sakai, R. R. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90296-9 · Cited by 88
The human kidney is a progesterone-metabolizing and androgen-producing organ
Quinkler, M., Bumke-Vogt, C., Meyer, B., Bähr, V., Oelkers, W., & Diederich, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021970 · Cited by 87
Salt-Sensitive Hypertension and the Kidney
Nishimoto, M., Griffin, K. A., Wynne, B. M., & Fujita, T. (2024) · Hypertension · doi:10.1161/hypertensionaha.123.21369 · Cited by 88
Smith, R. E., Li Kevin, X. Z., Andrews, R. K., & Krozowski, Z. (1997) · Endocrinology · doi:10.1210/endo.138.2.4926 · Cited by 79
Self-citationSeckl, J. R., & Chapman, K. E. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-1-00361.x · Cited by 77
Garbrecht, M. R., Klein, J. M., Schmidt, T. J., & Snyder, J. M. (2006) · Neonatology · doi:10.1159/000088653 · Cited by 72
“In these tissues, HSD2 has been shown to locally inactivate cortisol, thus preventing illicit occupation of the mineralocorticoid receptor (MR) by cortisol, since the MR has equal affinities for both aldosterone and cortisol [”
BackgroundBailey, M. A., Mullins, J. J., & Kenyon, C. J. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.134973 · Cited by 80
Aldosterone responsiveness of A6 cells is restored by cloned rat mineralocorticoid receptor
Chen, S.-Y., Wang, J., Liu, W., & Pearce, D. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.1.c39 · Cited by 87
Aldosterone-Regulated Sodium Transport and Blood Pressure
Tsilosani, A., Gao, C., & Zhang, W. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.770375 · Cited by 87
Sheppard, K. E., & Autelitano, D. J. (2002) · Endocrinology · doi:10.1210/endo.143.1.8583 · Cited by 76
Hirasawa, G., Sasano, H., Takahashi, K.-I., Fukushima, K., Suzuki, T., Hiwatashi, N., Toyota, T., Krozowski, Z. S., & Nagura, H. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4337 · Cited by 85
Rohde, J. J., Pliushchev, M. A., Sorensen, B. K., Wódka, D., Shuai, Q., Wang, J., Fung, S., Monzon, K., Chiou, W. J. H., Pan, L., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0609364 · Cited by 85
Subcellular Localization of the Type 2 11β-Hydroxysteroid Dehydrogenase
Náray-Fejes-Tóth, A., & Fejes-Tóth, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15436 · Cited by 75
Watson, B., Bergman, S. M., Myracle, A., Callen, D. F., Acton, R. T., & Warnock, D. G. (1996) · Hypertension · doi:10.1161/01.hyp.28.3.478 · Cited by 83
Brain mineralocorticoid receptors in cognition and cardiovascular homeostasis
Gómez-Sánchez, E. P. (2014) · Steroids · doi:10.1016/j.steroids.2014.08.014 · Cited by 84
“Very soon thereafter the role of 11b-HSD dehydrogenase activity in providing pre-receptor ligand selectivity to the MR for aldosterone in aldosterone target cells was demonstrated [199–206].”
BackgroundRauz, S., Cheung, C. M. G., Wood, P. J., Coca-Prados, M., Walker, E. A., Murray, P. I., & Stewart, P. M. (2003) · QJM · doi:10.1093/qjmed/hcg085 · Cited by 76
Holmes, M. C., Kotelevtsev, Y. V., Mullins, J. J., & Seckl, J. R. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00386-5 · Cited by 84
Rapid actions of aldosterone in vascular health and disease—friend or foe?
Skøtt, O., Uhrenholt, T. R., Schjerning, J., Hansen, P., Rasmussen, L. E., & Jensen, B. L. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.010 · Cited by 84
Bailey, T. L., Baker, M. E., & Elkan, C. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00013-7 · Cited by 84
Aldosterone and the vascular system
Cachofeiro, V., Miana, M., Heras, N. D. L., Martín‐Fernández, B., Ballesteros, S., Fernández-Tresguerres, J. Á., & Lahera, V. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.03.005 · Cited by 83
Geerling, J. C., & Loewy, A. D. (2006) · Journal of Comparative Neurology · doi:10.1002/cne.21019 · Cited by 81
“…level) of HSD2 expression by neurons in the amygdala is consistent with the ability of glucocorticoids to out-compete aldosterone for MR binding sites here (McEwen et al., 1986), in contrast to the aldosterone-selective cells in the kidney (Funder et al., 1988) and the NTS (Geerling et al., 2006a).”
BackgroundCentral hypertensinogenic effects of glycyrrhizic acid and carbenoxolone
Gomez-Sanchez, E. P., & Gomez-Sanchez, C. E. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.263.6.e1125 · Cited by 66
Distribution of 11 beta-hydroxysteroid dehydrogenase along the rabbit nephron.
Bonvalet, J. P., Doignon, I., Blot-Chabaud, M., Pradelles, P., & Farman, N. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114781 · Cited by 78
Orchinik, M., Matthews, L., & Gasser, P. J. (2000) · General and Comparative Endocrinology · doi:10.1006/gcen.2000.7462 · Cited by 82
Maser, E., Richter, E., & Friebertshäuser, J. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0484z.x · Cited by 83
Regulation of collecting duct AQP3 expression: response to mineralocorticoid
Kwon, T., Nielsen, J., Masilamani, S. M. E., Hager, H., Knepper, M. A., Frøkiær, J., & Nielsen, S. M. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00059.2002 · Cited by 82
“In addition, glucocorticoid binds to the aldosterone receptor, although this hormone does not act as a major mineralocorticoid due to degradation by 11- hydroxysteroid dehydrogenase (13).”
BackgroundThe 11β-hydroxysteroid dehydrogenases: functions and physiological effects
Krozowski, Z. S. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00256-1 · Cited by 82
11β-Hydroxysteroid Dehydrogenase and Its Role in the Syndrome of Apparent Mineralocorticoid Excess
White, P. C. (2001) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200112000-00003 · Cited by 82
Low, S. C., Moisan, M., Noble, J. M., Edwards, C. R. W., & Seckl, J. R. (1994) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1994.tb00584.x · Cited by 67
“The explanation of this apparent paradox resides in the activity of 1 1P-hydroxysteroid dehydrogenase ( 11bOHSD) (21, 22).”
BackgroundSato, A., Funder, J. W., & Saruta, T. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00066-7 · Cited by 82
Self-citationCentral hypertensinogenic effects of glycyrrhizic acid and carbenoxolone
Gomez-Sanchez, E. P., & Gomez-Sanchez, C. E. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2006.263.6.e1125 · Cited by 81
Natural Triterpenoids as Anti-Inflammatory Agents
Ríos, J. L., Recio, M. C., Máñez, S., & Giner, R. M. (2000) · Studies in natural products chemistry · doi:10.1016/s1572-5995(00)80024-1 · Cited by 81
Potassium Transport in the Mammalian Collecting Duct
Muto, S. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.85 · Cited by 80
“On the other hand, since the affinity of 11-dehydrocorticosterone and cortisone for the glucocorticoid receptor is also very low (86), 11b-OHSD is likely to affect binding and action of glucocorticoids via its own receptor as well.”
BackgroundInfluentialOng, G. S. Y., & Young, M. J. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0318 · Cited by 81
N'Gankam, V., Uehlinger, D. E., Dick, B., Frey, B. M., & Frey, F. J. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00308.x · Cited by 80
Brooks, H. L., Ageloff, S., Kwon, T., Brandt, W., Terris, J. M., Seth, A., Michea, L., Nielsen, S. M., Fenton, R. A., & Knepper, M. A. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00054.2002 · Cited by 80
“This enzyme is believed to play a central role in the regulation of ion transport in the renal collecting duct through its ability to break down glucocorticoids (cortisol in humans; corticosterone in rodents) to inactive forms (16).”
BackgroundApparent mineralocorticoid excess in a Brazilian kindred: hypertension in the heterozygote state
Li, A., Li, K. X. Z., Marui, S., Krozowski, Z. S., Batista, M. C., Whorwood, C. B., Arnhold, I. J. P., Shackleton, C. H. L., Mendonca, B. B., & Stewart, P. M. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715120-00005 · Cited by 75
Recent Research Advances in Renin-Angiotensin-Aldosterone System Receptors
Azushima, K., Morisawa, N., Tamura, K., & Nishiyama, A. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-1028-6 · Cited by 79
Corticosteroid actions on amino acid-mediated transmission in rat CA1 hippocampal cells
Joels, M., & de Kloet, E. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-09-04082.1993 · Cited by 76
Martinerie, L., Munier, M., Menuet, D. L., Méduri, G., Viengchareun, S., & Lombès, M. (2012) · Biochimie · doi:10.1016/j.biochi.2012.09.030 · Cited by 78
Michael, A. E., & COOKE, B. A. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90279-8 · Cited by 78
Askonas, L. J., Ricigliano, J. W., & Penning, T. M. (1991) · Biochemical Journal · doi:10.1042/bj2780835 · Cited by 73
Glucocorticoids and cognitive function: a walkthrough in endogenous and exogenous alterations
Alcubierre, D. D., Ferrari, D., Mauro, G. C. D., Isidori, A. M., Tomlinson, J., & Pofi, R. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02091-7 · Cited by 78
“…activation by GCs [21] in mineralocorticoid sensitive tissue, such as the kidney, placenta, colon, and salivary glands by converting them in their 11-oxo metabolites, allowing aldosterone to bind to MR despite its 100–1000-fold lower concentration in the bloodstream, compared to GCs [22].”
Background
Metadata
- Authors
- Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I.
- Affiliations
- Medical Research Centre, Prince Henry's Hospital, Melbourne, Australia 3004.
- Venue
- Science
- Published
- 1988-10-28
- Volume
- 242
- Issue
- 4878
- Pages
- 583-585
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2148114970
- Semantic Scholar
- ae47dabb539e84fc85ea0bfd3f1a669037f37264
- Cited by
- 1,628
- References
- 19
- Citations by year
- 2026: 15 · 2025: 7 · 2024: 21 · 2023: 21 · 2022: 16 · 2021: 25 · 2020: 25 · 2019: 32 · 2018: 32 · 2017: 33 · 2016: 26 · 2015: 30 · 2014: 37 · 2013: 44 · 2012: 56
- FWCI
- 30.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- mineralocorticoid receptor, aldosterone, glucocorticoids, cortisol, corticosterone, 11β-hydroxysteroid dehydrogenase, 11-keto steroids, kidney, parotid gland, colon, hippocampus, heart
- MeSH terms
- Adrenalectomy, Aldosterone, Animals, Carbenoxolone, Colon, Corticosterone, Heart, Hippocampus, Hydrocortisone, Hydroxysteroid Dehydrogenases, Kidney, Parotid Gland, Receptors, Steroid, Receptors, Mineralocorticoid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.